Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I
- PMID: 2997227
Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I
Abstract
Camptothecin, a cytotoxic drug, is a strong inhibitor of nucleic acid synthesis in mammalian cells and a potent inducer of strand breaks in chromosomal DNA. Neither the equilibrium dialysis nor the unwinding measurement indicates any interaction between camptothecin and purified DNA. However, camptothecin induces extensive single strand DNA breaks in reactions containing purified mammalian DNA topoisomerase I. DNA breakage in vitro is immediate and reversible. Analyses of camptothecin-induced DNA breaks show that topoisomerase I is covalently linked to the 3' end of the broken DNA. In addition, camptothecin inhibits the catalytic activity of mammalian DNA topoisomerase I. We propose that camptothecin blocks the rejoining step of the breakage-reunion reaction of mammalian DNA topoisomerase I. This blockage results in the accumulation of a cleavable complex which resembles the transient intermediate proposed for eukaryotic DNA topoisomerase I. The inhibition of nucleic acid synthesis and the induction of DNA strand breaks observed in vivo may be related to the formation of this drug-induced cleavable complex.
Similar articles
-
Intercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II.J Biol Chem. 1984 Jul 25;259(14):9182-7. J Biol Chem. 1984. PMID: 6086625
-
Induction of mammalian DNA topoisomerase I and II mediated DNA cleavage by saintopin, a new antitumor agent from fungus.Biochemistry. 1991 Jun 18;30(24):5838-45. doi: 10.1021/bi00238a005. Biochemistry. 1991. PMID: 1646001
-
Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin.Cancer Res. 1988 Apr 1;48(7):1722-6. Cancer Res. 1988. PMID: 2832051
-
International Commission for Protection Against Environmental Mutagens and Carcinogens. Mutagenicity and carcinogenicity of topoisomerase-interactive agents.Mutat Res. 1994 Aug 1;309(1):109-42. doi: 10.1016/0027-5107(94)90048-5. Mutat Res. 1994. PMID: 7519727 Review.
-
DNA topoisomerase I in oncology: Dr Jekyll or Mr Hyde?Pathol Oncol Res. 1999;5(3):171-8. doi: 10.1053/paor.1999.0209. Pathol Oncol Res. 1999. PMID: 10491013 Review.
Cited by
-
Why Should DNA Topoisomerase I Have a Scaffold Activity?Biology (Basel). 2021 Mar 3;10(3):190. doi: 10.3390/biology10030190. Biology (Basel). 2021. PMID: 33802574 Free PMC article. Review.
-
Hypoxia inducible factor pathway inhibitors as anticancer therapeutics.Future Med Chem. 2013 Apr;5(5):553-72. doi: 10.4155/fmc.13.17. Future Med Chem. 2013. PMID: 23573973 Free PMC article. Review.
-
Role of DNA topoisomerase I in the transcription of supercoiled rRNA gene.Proc Natl Acad Sci U S A. 1987 May;84(10):3185-8. doi: 10.1073/pnas.84.10.3185. Proc Natl Acad Sci U S A. 1987. PMID: 3033639 Free PMC article.
-
Synthesis, antitumor activity, and mechanism of action of 6-acrylic phenethyl ester-2-pyranone derivatives.Org Biomol Chem. 2015 Apr 28;13(16):4714-26. doi: 10.1039/c5ob00007f. Org Biomol Chem. 2015. PMID: 25800703 Free PMC article.
-
The basis for camptothecin enhancement of DNA breakage by eukaryotic topoisomerase I.Nucleic Acids Res. 1989 Nov 11;17(21):8521-32. doi: 10.1093/nar/17.21.8521. Nucleic Acids Res. 1989. PMID: 2555774 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials